# SOME DESCRIPTIVE TITLE.
# Copyright (C) YEAR THE PACKAGE'S COPYRIGHT HOLDER
# This file is distributed under the same license as the PACKAGE package.
# FIRST AUTHOR <EMAIL@ADDRESS>, YEAR.
#
#, fuzzy
msgid ""
msgstr ""
"Project-Id-Version: PACKAGE VERSION\n"
"Report-Msgid-Bugs-To: \n"
"POT-Creation-Date: 2020-05-16 18:00+0200\n"
"PO-Revision-Date: YEAR-MO-DA HO:MI+ZONE\n"
"Last-Translator: FULL NAME <EMAIL@ADDRESS>\n"
"Language-Team: LANGUAGE <LL@li.org>\n"
"Language: \n"
"MIME-Version: 1.0\n"
"Content-Type: text/plain; charset=UTF-8\n"
"Content-Transfer-Encoding: 8bit\n"
"Plural-Forms: nplurals=2; plural=(n != 1);\n"

#: BSPQ20E3/panel/templates/base.html:13
msgid "Title"
msgstr "Título"

#: BSPQ20E3/panel/templates/base.html:59
#: BSPQ20E3/panel/templates/basewithbar.html:79
msgid "My account"
msgstr "Mi cuenta"

#: BSPQ20E3/panel/templates/base.html:60
msgid "Log out"
msgstr "Cerrar sesión"

#: BSPQ20E3/panel/templates/base.html:65
#: BSPQ20E3/panel/templates/basewithbar.html:85
msgid "Sign in"
msgstr "Iniciar sesión"

#: BSPQ20E3/panel/templates/basewithbar.html:11
#, fuzzy
#| msgid "Social media"
msgid "Social login"
msgstr "Noticias"

#: BSPQ20E3/panel/templates/basewithbar.html:17
msgid "We only allow social login due to security and simplicity reasons"
msgstr ""
"Permitimos el inicio de sesión social por razones de seguridad y simplicidad"

#: BSPQ20E3/panel/templates/basewithbar.html:26
msgid "Close"
msgstr "Cerrar"

#: BSPQ20E3/panel/templates/basewithbar.html:38
#, fuzzy
#| msgid "My account"
msgid "Your account"
msgstr "Mi cuenta"

#: BSPQ20E3/panel/templates/basewithbar.html:47
#, fuzzy
#| msgid "My account"
msgid "Delete account"
msgstr "Mi cuenta"

#: BSPQ20E3/panel/templates/basewithbar.html:48
msgid "Save changes"
msgstr "Guardar cambios"

#: BSPQ20E3/panel/templates/basewithbar.html:49
msgid "Close without saving"
msgstr "Cerrar sin guardar"

#: BSPQ20E3/panel/templates/basewithbar.html:63
msgid "Main"
msgstr "General"

#: BSPQ20E3/panel/templates/basewithbar.html:67
msgid "Dashboard"
msgstr "Tablero"

#: BSPQ20E3/panel/templates/basewithbar.html:71
msgid "Live log"
msgstr "Log en vivo"

#: BSPQ20E3/panel/templates/basewithbar.html:73
msgid "User"
msgstr "Usuario"

#: BSPQ20E3/panel/templates/basewithbar.html:98
msgid "Configuration"
msgstr "Configuración"

#: BSPQ20E3/panel/templates/basewithbar.html:101
msgid "Settings"
msgstr "Ajustes"

#: BSPQ20E3/panel/templates/index.html:16
msgid "Overall"
msgstr "Resumen"

#: BSPQ20E3/panel/templates/index.html:17
#, fuzzy
#| msgid "Social media"
msgid "Social Media"
msgstr "Noticias"

#: BSPQ20E3/panel/templates/index.html:18
msgid "Recommendations"
msgstr "Recomendaciones"

#: BSPQ20E3/panel/templates/index.html:19
msgid "Economy"
msgstr "Economía"

#: BSPQ20E3/panel/templates/index.html:30
msgid "HEAT MAP OF CONFIRMED CASES"
msgstr "MAPA DE CALOR CON CASOS CONFIRMADOS"

#: BSPQ20E3/panel/templates/index.html:39
msgid "CONFIRMED CASES THROUGH TIME"
msgstr "CASOS CONFIRMADOS A LO LARGO DEL TIEMPO"

#: BSPQ20E3/panel/templates/index.html:46
msgid "DEATH NUMBER"
msgstr "NUMERO DE MUERTOS"

#: BSPQ20E3/panel/templates/index.html:47
msgid "CONFIRMED CASES"
msgstr "CASOS CONFIRMADOS"

#: BSPQ20E3/panel/templates/index.html:58
msgid "NEW CONFIRMED CASES"
msgstr "CASOS NUEVOS CONFIRMADOS"

#: BSPQ20E3/panel/templates/livelogtest.html:17
msgid "Filters"
msgstr "Filtros"

#: BSPQ20E3/panel/templates/livelogtest.html:28
msgid "Remove all filters"
msgstr "Borrar filtros"

#: BSPQ20E3/panel/templates/livelogtest.html:34
msgid "Country_Region"
msgstr "Países"

#: BSPQ20E3/panel/templates/livelogtest.html:35
msgid "Confirmed"
msgstr "Confirmados"

#: BSPQ20E3/panel/templates/livelogtest.html:36
msgid "Deaths"
msgstr "Muertos"

#: BSPQ20E3/panel/templates/livelogtest.html:37
msgid "Recovered"
msgstr "Recuperados"

#: BSPQ20E3/panel/templates/livelogtest.html:38
msgid "Last update"
msgstr "Ultima actualización"

#: BSPQ20E3/panel/templates/livelogtest.html:78
#: BSPQ20E3/panel/templates/livelogtest.html:81
msgid "Previous"
msgstr "Anterior"

#: BSPQ20E3/panel/templates/livelogtest.html:94
#: BSPQ20E3/panel/templates/livelogtest.html:96
msgid "Next"
msgstr "Siguiente"

#: BSPQ20E3/panel/templates/profile.html:15
msgid "Last login: "
msgstr "Ultimo inicio de sesion: "

#: BSPQ20E3/panel/templates/profile.html:23
msgid "About"
msgstr "Acerca de"

#: BSPQ20E3/panel/templates/profile.html:26
msgid "Timeline"
msgstr "Cronograma"

#: BSPQ20E3/panel/templates/profile.html:36
#, fuzzy
#| msgid "Email address"
msgid "Email: "
msgstr "Correo electrónico: "

#: BSPQ20E3/panel/templates/profile.html:40
msgid "Name: "
msgstr "Nombre: "

#: BSPQ20E3/panel/templates/recommendations.html:13
msgid "https://www.youtube.com/embed/sHP0UIdZyI4"
msgstr "https://www.youtube.com/embed/Tt9G39gzCFw"

#: BSPQ20E3/panel/templates/recommendations.html:17
msgid "COVID-19 is the name given to the disease associated with the virus."
msgstr "COVID-19 es el nombre dado a la enfermedad asociada con el virus."

#: BSPQ20E3/panel/templates/recommendations.html:18
msgid ""
"SARS-CoV-2 is a new strain of coronavirus that has not been previously "
"identified in humans."
msgstr ""
"El SARS-CoV-2 es una nueva cepa de coronavirus que no se ha identificado "
"previamente en humanos."

#: BSPQ20E3/panel/templates/recommendations.html:37
msgid "What are they?"
msgstr "¿Qué son?"

#: BSPQ20E3/panel/templates/recommendations.html:38
msgid ""
"Coronaviruses are viruses that circulate among animals with some of them "
"also known to infect humans. Bats are considered natural hosts of these "
"viruses yet several other species of animals are also known to act as "
"sources. For instance, Middle East Respiratory Syndrome Coronavirus (MERS-"
"CoV) is transmitted to humans from camels, and Severe Acute Respiratory "
"Syndrome Coronavirus-1 (SARS-CoV-1) is transmitted to humans from civet cats."
msgstr ""
"Los coronavirus son virus que circulan entre los animales y algunos de ellos "
"también se sabe que infectan a los humanos. Los murciélagos se consideran "
"anfitriones naturales de estos virus, aunque también se sabe que otras "
"especies de animales actúan como fuentes. Por ejemplo, el coronavirus del "
"síndrome respiratorio de Oriente Medio (MERS-CoV) se transmite a los humanos "
"desde los camellos, y el coronavirus-1 del síndrome respiratorio agudo "
"severo (SARS-CoV-1) se transmite a los humanos desde los gatos de civeta."

#: BSPQ20E3/panel/templates/recommendations.html:55
msgid "Where does the virus come from?"
msgstr "¿De dónde viene el virus?"

#: BSPQ20E3/panel/templates/recommendations.html:56
msgid ""
"While animals are believed to be the original source, the virus spread is "
"now from person to person (human-to-human transmission). There is not enough "
"epidemiological information at this time to determine how easily this virus "
"spreads between people, but it is currently estimated that, on average, one "
"infected person will infect between two and three other people. "
msgstr ""
"Si bien se cree que los animales son la fuente original, la propagación del "
"virus ahora es de persona a persona (transmisión de persona a persona). No "
"hay suficiente información epidemiológica en este momento para determinar "
"con qué facilidad este virus se propaga entre las personas, pero actualmente "
"se estima que, en promedio, una persona infectada infectará entre dos y tres "
"personas más."

#: BSPQ20E3/panel/templates/recommendations.html:72
msgid "How is the virus transmitted?"
msgstr "¿Cómo se transmite el virus?"

#: BSPQ20E3/panel/templates/recommendations.html:73
msgid ""
"The virus seems to be transmitted mainly via small respiratory droplets "
"through sneezing, coughing, or when people interact with each other for some "
"time in close proximity (usually less than one metre). These droplets can "
"then be inhaled, or they can land on surfaces that others may come into "
"contact with, who can then get infected when they touch their nose, mouth or "
"eyes. The virus can survive on different surfaces from several hours "
"(copper, cardboard) up to a few days (plastic and stainless steel). However, "
"the amount of viable virus declines over time and may not always be present "
"in sufficient numbers to cause infection."
msgstr ""
"El virus parece transmitirse principalmente a través de pequeñas gotas "
"respiratorias a través de estornudos, tos o cuando las personas interactúan "
"entre sí durante algún tiempo muy cerca (generalmente menos de un metro). "
"Estas gotitas se pueden inhalar o pueden aterrizar en superficies con las "
"que otros pueden entrar en contacto, que luego pueden infectarse cuando se "
"tocan la nariz, la boca o los ojos. El virus puede sobrevivir en diferentes "
"superficies desde varias horas (cobre, cartón) hasta unos pocos días "
"(plástico y acero inoxidable). Sin embargo, la cantidad de virus viable "
"disminuye con el tiempo y puede no estar siempre presente en cantidades "
"suficientes para causar infección."

#: BSPQ20E3/panel/templates/recommendations.html:89
msgid "When does the transmission occur?"
msgstr "¿Cuándo se produce la transmisión?"

#: BSPQ20E3/panel/templates/recommendations.html:90
msgid ""
"The incubation period for COVID-19 (i.e. the time between exposure to the "
"virus and onset of symptoms) is currently estimated to be between one and 14 "
"days."
msgstr ""
"El período de incubación de COVID-19 (es decir, el tiempo entre la "
"exposición al virus y el inicio de los síntomas) se estima actualmente entre "
"uno y 14 días. "

#: BSPQ20E3/panel/templates/recommendations.html:92
msgid ""
"We know that the virus can be transmitted when people who are infected show "
"symptoms such as coughing. There is also some evidence suggesting that "
"transmission can occur from a person that is infected even two days before "
"showing symptoms; however, uncertainties remain about the effect of "
"transmission by asymptomatic persons."
msgstr ""
"Sabemos que el virus puede transmitirse cuando las personas infectadas "
"muestran síntomas como tos. También hay alguna evidencia que sugiere que la "
"transmisión puede ocurrir de una persona infectada incluso dos días antes de "
"mostrar síntomas; sin embargo, persisten incertidumbres sobre el efecto de "
"la transmisión por personas asintomáticas."

#: BSPQ20E3/panel/templates/recommendations.html:109
msgid "What are the symptoms?"
msgstr "¿Cuáles son los síntomas?"

#: BSPQ20E3/panel/templates/recommendations.html:112
msgid "Fever"
msgstr "Fiebre"

#: BSPQ20E3/panel/templates/recommendations.html:113
msgid "Cough"
msgstr "Tos"

#: BSPQ20E3/panel/templates/recommendations.html:114
msgid "Sore throat"
msgstr "Dolor de garganta"

#: BSPQ20E3/panel/templates/recommendations.html:115
msgid "General weakness"
msgstr "Malestar general"

#: BSPQ20E3/panel/templates/recommendations.html:116
msgid "Fatigue and muscular pain"
msgstr "Fatiga y dolor muscular"

#: BSPQ20E3/panel/templates/recommendations.html:117
msgid "Severe pneumonia"
msgstr "Neumonía grave"

#: BSPQ20E3/panel/templates/recommendations.html:118
msgid "Acute respiratory distress syndrome"
msgstr "Sindrome de dificultad respiratoria aguda"

#: BSPQ20E3/panel/templates/recommendations.html:120
msgid ""
"Symptoms of COVID-19 vary in severity from having no symptoms at all (being "
"asymptomatic) to having fever, cough, sore throat, general weakness and "
"fatigue and muscular pain and in the most severe cases, severe pneumonia, "
"acute respiratory distress syndrome, sepsis and septic shock, all "
"potentially leading to death. Reports show that clinical deterioration can "
"occur rapidly, often during the second week of disease."
msgstr ""
"Los síntomas de COVID-19 varían en severidad desde no tener ningún síntoma "
"(estar asintomático) hasta tener fiebre, tos, dolor de garganta, debilidad "
"general y fatiga y dolor muscular y, en los casos más graves, neumonía "
"grave, síndrome de dificultad respiratoria aguda, sepsis y shock séptico, "
"todo lo cual puede conducir a la muerte. Los informes muestran que el "
"deterioro clínico puede ocurrir rápidamente, a menudo durante la segunda "
"semana de la enfermedad."

#: BSPQ20E3/panel/templates/recommendations.html:124
msgid ""
"Recently, anosmia – loss of the sense of smell – (and in some cases the loss "
"of the sense of taste) have been reported as a symptom of a COVID-19 "
"infection. There is already evidence from South Korea, China and Italy that "
"patients with confirmed SARS-CoV-2 infection have developed anosmia/"
"hyposmia, in some cases in the absence of any other symptoms."
msgstr ""
"Recientemente, se ha informado que la anosmia (pérdida del sentido del "
"olfato) (y en algunos casos la pérdida del sentido del gusto) es un síntoma "
"de una infección por COVID-19. Ya existe evidencia de Corea del Sur, China e "
"Italia de que los pacientes con infección confirmada por SARS-CoV-2 han "
"desarrollado anosmia / hiposmia, en algunos casos en ausencia de otros "
"síntomas."

#~ msgid "Search for"
#~ msgstr "Buscar"

#~ msgid "Language"
#~ msgstr "Idioma"

#~ msgid "Countries"
#~ msgstr "Países"

#~ msgid "Evolution"
#~ msgstr "Evolución"

#~ msgid "Tweets by CoronavirusESP"
#~ msgstr "Tweets por CoronavirusESP"

#~ msgid "Tweets by Covid_19Time"
#~ msgstr "Tweets por Covid_19Time"

#~ msgid "Dynamic Chart"
#~ msgstr "Tabla dinamica"

#~ msgid "by TradingView"
#~ msgstr "por TradingView"

#~ msgid "Sign in with"
#~ msgstr "Iniciar sesión con"

#~ msgid "COVID-19 cases in each country"
#~ msgstr "Casos de COVID-19 en cada país"

#~ msgid "Number of deaths in each country"
#~ msgstr "Número de muertos en cada país"

#~ msgid "Log in / Register"
#~ msgstr "Iniciar sesión / Registro"

#~ msgid "Login"
#~ msgstr "Iniciar sesión"

#~ msgid "Register"
#~ msgstr "Registro"

#~ msgid "Password"
#~ msgstr "Contraseña"

#~ msgid "Remember password"
#~ msgstr "Recordar contraseña"

#~ msgid "Sign up"
#~ msgstr "Registrarse"
